reports
Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Y...
Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones -- Preliminary unaudited net revenues from global sales of IMCIVREE® (setmelanotide) of approximately $42 million for the fourth quarter of 2024 and approximately $130 million for the full year of 2024 -- -- On track to report topline data from global Phase 3 trial evaluating setmelanotide in acquired hypothalamic obesity in the first half of 2025 -- -- Completed enrollment in supplemental Japanese cohort of Phase 3 trial of setmelanotide in a...
ARRAY Technologies Names Darin Green as Chief Revenue Officer for Nort...
ARRAY Technologies Names Darin Green as Chief Revenue Officer for North America Green brings extensive global experience in renewables, strategy, and cross-functional revenue leadership ALBUQUERQUE, N.M., Jan. 06, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading provider of tracker solutions and services for utility-scale solar energy projects, has named Darin Green as its chief revenue officer for North America, effective today, January 6. Green will report directly to ARRAY’s chief executive officer, Kevin G. Hostetler. Over a career ...
Palomar Holdings, Inc. Completes Acquisition of First Indemnity of Ame...
Palomar Holdings, Inc. Completes Acquisition of First Indemnity of America Insurance Company LA JOLLA, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ: PLMR) (“Palomar” or the “Company”) today announced the completion of the Company’s acquisition of First Indemnity of America Insurance Company (“FIA”), effective January 1, 2025. “I am very excited to announce the completion of our acquisition of FIA and to welcome FIA’s management team, employees and insureds to Palomar,” commented Mac Armstrong, Palomar’s Chairman and Chief Executive Officer. “This transaction p...
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanot...
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for IMCIVREE® (setmelanotide) to include children as young as 2 years old. IMCIVREE is indicated to reduce excess body weight and maintain weight reduction long-t...
- Jonathan Moreland
MMS MAXIMUS INC.
KVHI KVH INDUSTRIES INC.
GLP GLOBAL PARTNERS LP
CULP CULP INC.
GTN GRAY TELEVISION INC.
PETS PETMED EXPRESS INC.
PLSE PULSE BIOSCIENCES
TDW TIDEWATER INC
QRTEA QURATE RETAIL INC. CLASS A
RZLT REZOLUTE
ARRY INC.
RCAT ARRAY TECHNOLOGIES
TKO RED CAT HLDGS INC
SUNS TKO GROUP HOLDINGS
SPGC INC.
SUNRISE REALTY TRUST
SPARTA SURGICAL CORP
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Growth Leading This EOY Rally; Expect More Upside Our outlook remains bullish and we see the market in the midst of a significant end-of-year rally that we have been expecting since mid-October. We continue to expect support at the 20-day MAs on the S&P 500 and Nasdaq 100 (QQQ), while support at current levels or the 50-day MA is likely on the Russell 2000 (IWM). Ultimately, we will remain bullish as long as the S&P 500 is above 5850. Market dynamics continue to improve, giving us confidence th...
VIAV VIAVI SOLUTIONS INC
MEI METHODE ELECTRONICS INC.
LPTH LIGHTPATH TECHNOLOGIES INC. CL A
INFN INFINERA CORPORATION
GLW CORNING INC
EXTR EXTREME NETWORKS INC.
DGII DIGI INTERNATIONAL INC.
CIEN COMMSCOPE HOLDING CO. INC.
CASY CIENA CORPORATION
APH CASEY'S GENERAL STORES INC.
SILC AMPHENOL CORPORATION CLASS A
AAOI SILICOM LTD.
BELFB APPLIED OPTOELECTRONICS INC.
CAAP BEL FUSE INC. CL B
COMM CORPORACION AMERICA AIRPORTS
NTGR BMO GLOBAL COMMUNICATIONS INDEX ETF
NETANEL GROUP LTD
- Wedbush Research
WDC WESTERN DIGITAL CORPORATION
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
AXTI AXT INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
SMCI SUPER MICRO COMPUTER
IDYA INC.
CSR IDEAYA BIOSCIENCES
STX CENTERSPACE
GFS SEAGATE TECHNOLOGY HLDGS PLC
GLOBALFOUNDRIES INC
- Brian Violino
- Jay McCanless
- Wedbush Research
VIRC VIRCO MANUFACTURING CORP.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TRNO TERRENO REALTY CORPORATION
TOL TOLL BROTHERS INC.
LTC LTC PROPERTIES INC.
KURA KURA ONCOLOGY INC.
CXW CORECIVIC INC.
CMRX CHIMERIX INC
PTGX PROTAGONIST THERAPEUTICS
LRMR LARIMAR THERAPEUTICS INC
AIRC APARTMENT INCOME REIT
GMTX GEMINI THERAPEUTICS INC
HR HEALTHCARE TRUST OF AMERICA INC.
- Brian Violino
- Jay McCanless
ARRAY Technologies and RP Surpass 6GW of Solar Power Deployed
ARRAY Technologies and RP Surpass 6GW of Solar Power Deployed ARRAY and RP’s long-time partnership surpasses 6GW of solar power ALBUQUERQUE, N.M., Dec. 04, 2024 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a global leader in solar tracker solutions, announced today that it has deployed more than 6GW of solar projects in North America through its partnership with RP Construction Services (RP), a leading value-added distributor of solar construction materials. The ARRAY and RP teams have worked together since 2009 to serve leading solar developers and...
ARRAY Technologies Names H. Keith Jennings as Chief Financial Officer
ARRAY Technologies Names H. Keith Jennings as Chief Financial Officer Jennings brings over 30 years global experience in financial strategy, capital markets, and corporate transformation ALBUQUERQUE, N.M., Dec. 03, 2024 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading provider of tracker solutions and services for utility-scale solar energy projects, has named H. Keith Jennings as its chief financial officer, effective January 6, 2025. Jennings will report directly to ARRAY’s Chief Executive Officer, Kevin G. Hostetler. With a career spanni...
Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives ...
Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to include Children as Young as 2 Years Old BOSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that the United Kingdom’s Medicines & Healthcare products Regu...
- Jonathan Moreland
OPK OPKO HEALTH INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
MCHX MARCHEX INC. CL B
LTRX LANTRONIX INC.
HSII HEIDRICK & STRUGGLES INTERNATIONAL INC.
HASI
I3N HANNON ARMSTRONG SUSTAINABLE INFRASTRUCTURE CAPITAL INC.
EXAS CHART INDUSTRIES INC.
EL EXACT SCIENCES CORPORATION
CROX ESTEE LAUDER COMPANIES INC. CLASS A
CNC CROCS INC.
BRKR CENTENE CORPORATION
APPS BRUKER CORPORATION
AVNW DIGITAL TURBINE
AIN AVIAT NETWORKS
CMCO ALBANY INTERNATIONAL CORP. CLASS A
ENPH COLUMBUS MCKINNON CORPORATION
HTLD ENPHASE ENERGY INC.
SACH HEARTLAND EXPRESS INC.
DMLP SACHEM CAPITAL
HLNE DORCHESTER MINERALS L.P.
ANGI HAMILTON LANE INCORPORATED CLASS A
MBIN ANGI INC. CLASS A
LILA MERCHANTS BANCORP
FF LIBERTY LATIN AMERICA A
MEC FIRST MINING GOLD
NOVA MAYVILLE ENGINEERING
GRWG SUNNOVA ENERGY INTERNATIONAL
PCB GROWGENERATION
CLDX PACIFIC CITY FINANCIAL CORP
FBRX CELLDEX THERAPEUTICS INC.
TFC FORTE BIOSCIENCES INC
ONEW TRUIST FINANCIAL CORP
ARRY ONEWATER MARINE
SSSS ARRAY TECHNOLOGIES
ABCL SUTTER ROCK CAPITAL CORP.
CSU ABCELLERA BIOLOGICS
IMNM CAPITAL SENIOR LIVING
GRNT IMMUNOME
PFBX GRANIT SKOPKE
TRIN PEOPLES FINANCIAL CORP. (MISSISSIPPI)
ZETA TRINITY CAPITAL INC
RWAY ZETA GLOBAL HLDGS CORP
ANTX RUNWAY GROWTH FINANCE CORP
NXGL AN2 THERAPEUTICS INC
CALC NEXGEL INC
DBD CALCIMEDICA INC.
CATX DIEBOLD NIXDORF INCORPORATED
MDRR PERSPECTIVE THERAPEUTICS
PDYN INC.
DC MEDALIST DIVERSIFIED REIT INC.
AGFY SARCOS TECHNOLOGY AND ROBOTICS CORP
ETS DAKOTA GOLD CORP.
AGRIFY CORPORATION
ENTERASYS NETWORKS INC /DE/
- Jonathan Moreland
PSEC PROSPECT CAPITAL CORPORATION
MYE MYERS INDUSTRIES INC.
MPAA MOTORCAR PARTS OF AMERICA INC.
LTRX LANTRONIX INC.
GLP GLOBAL PARTNERS LP
EL ESTEE LAUDER COMPANIES INC. CLASS A
BRKR BRUKER CORPORATION
AXSM AXSOME THERAPEUTICS
APPS DIGITAL TURBINE
ACRS ACLARIS THERAPEUTICS INC.
MEDP MEDPACE HOLDINGS INC.
ENPH ENPHASE ENERGY INC.
ISTR INVESTAR HOLD
FRD FRIEDMAN INDUSTRIES INC.
SACH SACHEM CAPITAL
MBIN MERCHANTS BANCORP
LILA LIBERTY LATIN AMERICA A
FF FIRST MINING GOLD
ETST EARTH SCIENCE TECH
TCPC BLACKROCK TCP CAPITAL CORP.
NOVA SUNNOVA ENERGY INTERNATIONAL
GRWG GROWGENERATION
PCB PACIFIC CITY FINANCIAL CORP
FBRX FORTE BIOSCIENCES INC
TFC TRUIST FINANCIAL CORP
ONEW ONEWATER MARINE
ARRY ARRAY TECHNOLOGIES
SSSS SUTTER ROCK CAPITAL CORP.
ABCL ABCELLERA BIOLOGICS
CSU CAPITAL SENIOR LIVING
IMNM IMMUNOME
GRNT GRANIT SKOPKE
OSCR OSCAR HEALTH
WOLF WOLFSPEED INC
CLVT CLARIVATE PLC
ZETA ZETA GLOBAL HLDGS CORP
RWAY RUNWAY GROWTH FINANCE CORP
ANTX AN2 THERAPEUTICS INC
CGBD TCG BDC
NXGL INC.
HR NEXGEL INC
CARV HEALTHCARE TRUST OF AMERICA INC.
PFHC CARVER BANCORP INC
EP PROFRAC HLDG CORP
CATX EMPIRE PETROLEUM CORP
ASMB PERSPECTIVE THERAPEUTICS
DC INC.
FGF ASSEMBLY BIOSCIENCES INC
AGFY DAKOTA GOLD CORP.
FG FINANCIAL GROUP
INC.
AGRIFY CORPORATION
- Jonathan Moreland
EL ESTEE LAUDER COMPANIES INC. CLASS A
APPS DIGITAL TURBINE
BRKS BROOKS AUTOMATION INC.
FF FIRST MINING GOLD
NOVA SUNNOVA ENERGY INTERNATIONAL
ARRY ARRAY TECHNOLOGIES
CSU CAPITAL SENIOR LIVING
ZETA ZETA GLOBAL HLDGS CORP
CGBD TCG BDC
DOUG INC.
SES DOUGLAS ELLIMAN INC
KLG_w SES AI CORPORATION
DC WK KELLOGG CO
DAKOTA GOLD CORP.
ARRAY Announces $3 Million Investment in Swap Robotics to Drive Automa...
ARRAY Announces $3 Million Investment in Swap Robotics to Drive Automation in PV Installation Investment will encourage innovation, cost-saving solutions for solar energy projects worldwide ALBUQUERQUE, N.M., Nov. 18, 2024 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a global leader in solar tracker technology, is proud to announce its strategic $3 million investment in Swap Robotics, a pioneer in utility-scale solar robotic operations, maintenance, and automation solutions. This investment aligns with ARRAY’s ongoing commitment to innovation, sustai...
ARRAY Technologies Appoints Two Industry Veterans to Lead EMEA
ARRAY Technologies Appoints Two Industry Veterans to Lead EMEA ALBUQUERQUE, N.M., Nov. 18, 2024 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a global leader in solar tracker solutions, announces the appointment of Leonardo Serpa as general manager, Europe, the Middle East, and Africa (EMEA) and Héctor Sánchez as vice president of sales, EMEA. Both executives bring a wealth of experience to ARRAY’s growing operations in Europe, the Middle East, and Africa. Serpa joins ARRAY after serving as chief executive officer at Essentia Energia, where he led neg...
Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, incl...
Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide -- Four Pediatric patients treated in French early-access program achieved meaningful weight reduction at three months on setmelanotide therapy -- -- Rhythm announced plans for a new substudy to evaluate setmelanotide therapy in patients with congenital hypothalamic obesity -- BOSTON, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceut...
Rhythm Pharmaceuticals Inc: 2 directors
Two Directors at Rhythm Pharmaceuticals Inc sold after exercising options/sold 80,142 shares at between 66.330USD and 66.436USD. The significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.